SynBioBeta Speaker
Eric Lee
Primient
Director, B&D - Fermentation
Eric is a seasoned leader and recognized expert in the fermentation and bioprocessing industry, bringing more than 35 years of experience spanning technical innovation, commercialization, and strategic market development. In his current role at Primient, Eric leads the advancement of fermentation-based growth initiatives, positioning these solutions as a key strategic market segment for the company. He identifies, evaluates, and develops high-impact strategic partnerships that leverage Primient’s current and evolving biosolutions capabilities. In addition, Eric provides deep technical and commercial support for Primient’s ingredient portfolio serving fermentation and biomanufacturing customers, and plays a key role in evaluating new product development opportunities. Throughout his career, Eric has held leadership roles across the full fermentation life cycle, including fermentation optimization, strain selection, process scale-up, and large-scale manufacturing. He has successfully led cross-functional teams through the development and commercialization of novel fermentation-based products, translating complex science into scalable, market-ready solutions. His combined technical depth and business acumen have made him a trusted leader in business development and market strategy within the bioprocessing sector. Eric earned Bachelor of Science degrees in Biology and Chemistry from Manchester University and is a current member of the Society for Industrial Microbiology and Biotechnology (SIMB). An active and soughtafter industry speaker, Eric regularly presents at conferences and industry events, sharing insights on fermentation technologies, bioindustrial market trends, and commercialization pathways. Through his speaking engagements and industry involvement, he is recognized as a thought leader helping shape the future of fermentation and the broader bioeconomy.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Eric
This Year
•
-
Biomanufacturing
Full Stack Bio: How Can Biotech Collaborate to Achieve Scale with Competitive COGS
Scaling bio-based products requires integrated technical collaboration across strain engineering, fermentation, downstream processing, and analytics. Full-stack approaches—where startups, CDMOs, and platform technology providers align early on—can optimize yield, reduce variability, and lower cost of goods (COGS) at commercial scale. This session explores case studies of cross-company collaboration, from co-development of microbial strains and bioreactor designs to shared process analytics and predictive modeling. Hear how teams are breaking down technical silos to accelerate scale-up, improve reproducibility, and create competitive, sustainable manufacturing solutions that bring synthetic biology products from the lab to the market efficiently.
Get a Ticket
Featuring
Jamie Bacher
Huxley Project
Principal
Ag-biotech veteran guiding tech to market.
Babu Raman
Corteva Agriscience
External Collab. Portfolio Leader
Colby Adolph
Evonik
Sales Director
Fermentation scale-up connector: turning prototypes into manufacturable reality
Ling Li
ADM
Dir. Market Dev., Prec. Ferm.
Precision fermentation dealmaker bridging startups, scale, and brands
Eric Lee
Primient
Director, B&D - Fermentation
Blake Simmons
LBNL
Dir. Bio. Sys & Engg
Ionic-liquid biomass deconstruction pioneer; National Academy of Inventors fellow.
•
-
Biomanufacturing
Full Stack Bio: How Can Biotech Collaborate to Achieve Scale with Competitive COGS
Scaling bio-based products requires integrated technical collaboration across strain engineering, fermentation, downstream processing, and analytics. Full-stack approaches—where startups, CDMOs, and platform technology providers align early on—can optimize yield, reduce variability, and lower cost of goods (COGS) at commercial scale. This session explores case studies of cross-company collaboration, from co-development of microbial strains and bioreactor designs to shared process analytics and predictive modeling. Hear how teams are breaking down technical silos to accelerate scale-up, improve reproducibility, and create competitive, sustainable manufacturing solutions that bring synthetic biology products from the lab to the market efficiently.
Get a Ticket
Featuring
Jamie Bacher
Huxley Project
Principal
Ag-biotech veteran guiding tech to market.
Babu Raman
Corteva Agriscience
External Collab. Portfolio Leader
Colby Adolph
Evonik
Sales Director
Fermentation scale-up connector: turning prototypes into manufacturable reality
Ling Li
ADM
Dir. Market Dev., Prec. Ferm.
Precision fermentation dealmaker bridging startups, scale, and brands
Eric Lee
Primient
Director, B&D - Fermentation
Blake Simmons
LBNL
Dir. Bio. Sys & Engg
Ionic-liquid biomass deconstruction pioneer; National Academy of Inventors fellow.
Session lineup still growing
Get a Ticket
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Get a Ticket
Featuring
Speaker Coming Soon
